Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by ircm doc
Group name EquipeCTCS
Item Type Journal Article
Title Multiple Fra-1-bound enhancers showing different molecular and functional features can cooperate to repress gene transcription
Creator Bejjani et al.
Author Fabienne Bejjani
Author Emilie Evanno
Author Samantha Mahfoud
Author Claire Tolza
Author Kazem Zibara
Author Marc Piechaczyk
Author Isabelle Jariel-Encontre
Abstract BACKGROUND: How transcription factors (TFs) down-regulate gene expression remains ill-understood, especially when they bind to multiple enhancers contacting the same gene promoter. In particular, it is not known whether they exert similar or significantly different molecular effects at these enhancers. RESULTS: To address this issue, we used a particularly well-suited study model consisting of the down-regulation of the TGFB2 gene by the TF Fra-1 in Fra-1-overexpressing cancer cells, as Fra-1 binds to multiple enhancers interacting with the TGFB2 promoter. We show that Fra-1 does not repress TGFB2 transcription via reducing RNA Pol II recruitment at the gene promoter but by decreasing the formation of its transcription-initiating form. This is associated with complex long-range chromatin interactions implicating multiple molecularly and functionally heterogeneous Fra-1-bound transcriptional enhancers distal to the TGFB2 transcriptional start site. In particular, the latter display differential requirements upon the presence and the activity of the lysine acetyltransferase p300/CBP. Furthermore, the final transcriptional output of the TGFB2 gene seems to depend on a balance between the positive and negative effects of Fra-1 at these enhancers. CONCLUSION: Our work unveils complex molecular mechanisms underlying the repressive actions of Fra-1 on TGFB2 gene expression. This has consequences for our general understanding of the functioning of the ubiquitous transcriptional complex AP-1, of which Fra-1 is the most documented component for prooncogenic activities. In addition, it raises the general question of the heterogeneity of the molecular functions of TFs binding to different enhancers regulating the same gene.
Publication Cell & Bioscience
Volume 13
Issue 1
Pages 129
Date 2023-07-18
Journal Abbr Cell Biosci
Language eng
DOI 10.1186/s13578-023-01077-5
ISSN 2045-3701
Library Catalog PubMed
Extra PMID: 37464380 PMCID: PMC10354941
Tags AP-1, CBP, Enhancer, first-last-corresponding, FOSL1, Fra-1, last, original, p300, phd, Transcription repression
Date Added 2025/01/13 - 12:00:51
Date Modified 2025/01/16 - 09:50:44
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés